ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases (Q65538404)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases |
clinical trial |
Statements
Randomised Open-label Multicenter Prosp. Clinical Study to Show the Efficacy of IV ZOMETA® 4mg for Prevention of Bone Metastases in Hormone-naïve High Risk Patients With Locally Advanced Prostate Cancer (English)
0 references
December 2003
0 references
December 2003
0 references
376
0 references
18 year
0 references